Le livre est actuellement en rupture de stock
En savoir plus sur le livre
The book delves into the evolution of drug testing since the late 1990s, focusing on the geneticization of carcinogenic risk assessment and pharmaceutical regulation. It explores critical issues in bio-science and medical treatment, questioning what knowledge is deemed essential for assessing carcinogenic risks to humans and examining the processes behind these judgments. Through this analysis, it highlights the implications for patient health and the complexities involved in pharmaceutical regulation.
Achat du livre
Controlling Pharmaceutical Risks, Rachel Ballinger, John Abraham
- Langue
- Année de publication
- 2025
- product-detail.submit-box.info.binding
- (rigide)
Nous vous informerons par e-mail dès que nous l’aurons retrouvé.
Modes de paiement
Personne n'a encore évalué .